Rev. Fr. Emmanuel Lemelson Renews Call for Investigation in Alleged Accounting and Securities Fraud, SEC Failures, at Ligand Pharmaceuticals

[In The News]

MARLBOROUGH, Mass., Jan. 16, 2019 /PRNewswire/ -- Rev. Fr. Emmanuel Lemelson, the CIO of Lemelson Capital Management, LLC, a U.S.-based global Investment management firm, today renewed calls for an investigation in Ligand Pharmaceuticals (NASDAQ: LGND), a U.S.-based publicly-traded...

View the full article